Staphylococcus aureus FadB is a dehydrogenase that mediates cholate resistance and survival under human colonic conditions. Issue 3 (22nd March 2023)

• Record Type: Journal Article
• Authors: Alsultan, Amjed; Walton, Gemma; Andrews, Simon C.; Clarke, Simon R.
• Is Part Of: Microbiology. Volume 169:Issue 3(2023)
• Publication Date: 2023-03-22
• Subjects: Staphylococcus aureus -- FadB -- dehydrogenase -- cholate -- bile acids -- colon; Microbiology -- Periodicals; 579
• DOI: 10.1099/mic.0.001314
• Languages: English
• ISSNs: 1350-0872

Abstract

Abstract : Staphylococcus aureus is a common colonizer of the human gut and in doing so it must be able to resist the actions of the host's innate defences. Bile salts are a class of molecules that possess potent antibacterial activity that control growth. Bacteria that colonize and survive in that niche must be able to resist the action of bile salts, but the mechanisms by which S. aureus does so are poorly understood. Here we show that FadB is a bile-induced oxidoreductase which mediates bile salt resistance and when heterologously expressed in Escherichia coli renders them resistant. Deletion of fadB attenuated survival of S. aureus in a model of the human distal colon.